Role of free PSA in discordance across commercial PSA assays

Clinical Chemistry

Volumn 42, Issue 4, 1996, Pages 645-647

  Strobel, Susan ^a   Smith, Katie ^a   Wolfert, Robert ^a   Rittenhouse, Harry ^a  

^a Hybritech Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; IMMUNOASSAY; PROSTATE CANCER;

EID: 0029968630     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.4.645     Document Type: Article

References (18)

1. Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989;142:1011-7.
2. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-90.
3. Myrtle JF, Ivor LP. Measurement of prostate-specific antigen (PSA) in serum by a two-site immunometric method. In: Catalona WJ, Coffey DS, Karr JP, eds. Clinical aspects of prostate cancer. New York: Elsevier Science, 1989:161-71.
4. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Terry WJ, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990;143:1146-54.
5. Colberg JW, Smith DS, Catalona WJ. Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 μg/L. J Urol 1993;149:507-9.
6. Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM. A prostate antigen in sera of prostatic cancer patients. Cancer Res 1980;40:2428-32.
7. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6.
8. Brawer MK, Daum P, Petteway JC, Wener MH. Assay variability in serum prostate-specific antigen determination. Prostate 1995;26:1-6.
9. Jacobsen SJJ, Lilja H, Klee GG, Wright GL, Pettersson K. Oesterling JE. Comparability of the Tandem R and IMx assays for the measurement of serum prostate-specific antigen. Urology 1994;44:512-8.
10. Wang TJ, Hill T, Norton K, Sokoloff R, Frankenne F, Rittenhouse HG, Wolfert RL. Specific immunoassay for free PSA and its clinical relevance [Abstract]. J Urol 1995;153:295A.
11. Parrish D, Lewandowski D, Vales S, Mangassarian H. Evaluation of the Abbott prostatic specific antigen (PSA) on the IMx [Abstract]. Clin Chem 1993;39:1189.
12. Vessella R, Noteboom J, Lange PH. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen. Clin Chem 1992;38:2044-54.
13. Sampson M, Ruddel M, Elin RJ, Abbott IMx, immunoradiometric methods for prostatic specific antigen compared [Abstract]. Clin Chem 1992;38:949.
14. Klee G, Dodge LA, Zincke H, Oesterling JE. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay. J Urol 1994;151:94-8.
15. Bankson DD, Lyon ME, Costales LV, Haver VM. The response of assays for total prostate specific antigen to changing proportions of "free" and alpha-1-antichymotrypsin bound PSA [Abstract]. Clin Chem 1994;40:1009.
16. Graves HCB. Standardization of immunoassays for prostate-specific antigen. Cancer 1993;72:3141-4.
17. Graves HCB. Issues on standardization of immunoassays for prostate-specific antigen: a review. Clin Invest Med 1993;16:416-25.
18. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274:1214-20.